Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Protein Accumulation in Traumatic Brain Injury

  • Douglas H. Smith
  • , Kunihiro Uryu
  • , Kathryn E. Saatman
  • , John Q. Trojanowski
  • , Tracy K. McIntosh

Producción científica: Articlerevisión exhaustiva

129 Citas (Scopus)

Resumen

Traumatic brain injury (TBI) is one of the most devastating diseases in our society, accounting for a high percentage of mortality and disability. A major consequence of TBI is the rapid and long-term accumulation of proteins. This process largely reflects the interruption of axonal transport as a result of extensive axonal injury. Although many proteins are found accumulating after TBI, three have received particular attention; β-amyloid precursor protein and its proteolytic products, amyloid-β (Aβ) peptides, neurofilament proteins, and synuclein proteins. Massive coaccumulations of all of these proteins are found in damaged axons throughout the white matter after TBI. Additionally, these proteins form aggregates in other neuronal compartments and in brain parenchyma after brain trauma. Interestingly, TBI is also an epigenetic risk factor for developing neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease. Here, the similarities and differences of these accumulations with pathologies of neurodegenerative diseases will be explored. In addition, the potential deleterious roles of protein accumulations on functional outcome and progressive neurodegeneration following TBI will be examined.

Idioma originalEnglish
Páginas (desde-hasta)59-72
Número de páginas14
PublicaciónNeuroMolecular Medicine
Volumen4
N.º1-2
DOI
EstadoPublished - 2003

Nota bibliográfica

Funding Information:
This work was supported, in part, by grants from the National Institute of Neurological Disorders and Stroke (P50-NS08803 and RO1-NS40978 to T.K.M.); the National Institute of General Medical Sciences (RO1-GM34790 to T.K.M.), National Institutes of Health (NIH) grants NS38104 (to D.H.S.), AG12527 (to D.H.S.), AG11542 (to J.Q.T.), AG-10124 (to J.Q.T.), and NS-45131 (to K.E.S.); a Merit Review grant from the Veterans Administration (to T.K.M.); and a Veterans Administration-DOD consortium Merit Review grant (to T.K.M.).

Financiación

This work was supported, in part, by grants from the National Institute of Neurological Disorders and Stroke (P50-NS08803 and RO1-NS40978 to T.K.M.); the National Institute of General Medical Sciences (RO1-GM34790 to T.K.M.), National Institutes of Health (NIH) grants NS38104 (to D.H.S.), AG12527 (to D.H.S.), AG11542 (to J.Q.T.), AG-10124 (to J.Q.T.), and NS-45131 (to K.E.S.); a Merit Review grant from the Veterans Administration (to T.K.M.); and a Veterans Administration-DOD consortium Merit Review grant (to T.K.M.).

FinanciadoresNúmero del financiador
Veterans Administration
Veterans Administration-DOD consortium
National Institutes of Health (NIH)AG-10124, AG12527, NS-45131, NS38104, AG11542
National Institute of General Medical SciencesRO1-GM34790
National Institute of Neurological Disorders and StrokeRO1-NS40978, P50NS008803

    ASJC Scopus subject areas

    • Molecular Medicine
    • Neurology
    • Cellular and Molecular Neuroscience

    Huella

    Profundice en los temas de investigación de 'Protein Accumulation in Traumatic Brain Injury'. En conjunto forman una huella única.

    Citar esto